Export 2717 results:
Author Title Type [ Year(Asc)]
1985
D. M. Stablein, “Therapeutic synergism.”, Biometrics, vol. 41, no. 4, pp. 1076-7, 1985.
K. V. Shepard, Levin, B., Karl, R. C., Faintuch, J., DuBrow, R. A., Hagle, M., Cooper, R. M., Beschorner, J., and Stablein, D., “Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.”, J Clin Oncol, vol. 3, no. 2, pp. 161-9, 1985.
D. M. Stablein and Koutrouvelis, I. A., “A two-sample test sensitive to crossing hazards in uncensored and singly censored data.”, Biometrics, vol. 41, no. 3, pp. 643-52, 1985.
1983
F. P. Smith, Stablein, D., Korsmeyer, S., Neefe, J., Chun, B. K., Woolley, P. V., and Schein, P. S., “Combination chemotherapy for locally advanced pancreatic cancer: equivalence to external beam irradiation and implication for future management.”, J Clin Oncol, vol. 1, no. 7, pp. 413-5, 1983.
D. M. Stablein, Carter, W. H., and Wampler, G. L., “Confidence regions for constrained optima in response-surface experiments.”, Biometrics, vol. 39, no. 3, pp. 759-63, 1983.
1982
W. H. Carter, Wampler, G. L., Stablein, D. M., and Campbell, E. D., “Drug activity and therapeutic synergism in cancer treatment.”, Cancer Res, vol. 42, no. 8, pp. 2963-71, 1982.
H. W. Bruckner, Lokich, J. J., and Stablein, D. M., “Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.”, Cancer Treat Rep, vol. 66, no. 9, pp. 1713-7, 1982.
1981
D. M. Stablein, Carter, W. H., and Novak, J. W., “Analysis of survival data with nonproportional hazard functions.”, Control Clin Trials, vol. 2, no. 2, pp. 149-59, 1981.
S. Zimm, Wampler, G. L., Stablein, D., Hazra, T., and Young, H. F., “Intracerebral metastases in solid-tumor patients: natural history and results of treatment.”, Cancer, vol. 48, no. 2, pp. 384-94, 1981.
R. P. Greenberg, Stablein, D. M., and Becker, D. P., “Noninvasive localization of brain-stem lesions in the cat with multimodality evoked potentials: correlation with human head-injury data.”, J Neurosurg, vol. 54, no. 6, pp. 740-50, 1981.
1980
D. M. Stablein, Miller, J. D., Choi, S. C., and Becker, D. P., “Statistical methods for determining prognosis in severe head injury.”, Neurosurgery, vol. 6, no. 3, pp. 243-8, 1980.
D. M. Stablein, Carter, W. H., and Wampler, G. L., “Survival analysis of drug combinations using a hazards model with time-dependent covariates.”, Biometrics, vol. 36, no. 3, pp. 537-46, 1980.
1976
J. C. Hagege and Pollet, J., “[The dome dogma].”, Ann Chir Plast, vol. 21, no. 3, pp. CP215-8, 1976.
K. Takamura and Watanabe, F., “Polarographic studies of the oxidation of vitamin K5 in aqueous solution.”, Anal Biochem, vol. 74, no. 2, pp. 512-20, 1976.
1975
C. Groh and Rosenmayr, F. W., “[Borderline between antiepileptic and psychopharmacological drugs (author's transl)].”, Padiatr Padol, vol. 10, no. 2, pp. 131-9, 1975.
E. A. Hordiénko, Sydorova, O. M., and Efremova, H. H., “[Properties of glutamine synthetase of the brain of rats during ontogenesis].”, Ukr Biokhim Zh, vol. 47, no. 1, pp. 65-9, 1975.
M. Kosakai and Yosizawa, Z., “A rapid method for seperation and identification of several hexuronic acids and hexuronic acid-containing oligosaccharides.”, Anal Biochem, vol. 69, no. 2, pp. 415-9, 1975.